Unique Crypto Strategies
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

Unique Crypto Strategies

Investing

ChemX Receives $661,890 R&D Refund

by November 14, 2024
November 14, 2024
ChemX Receives $661,890 R&D Refund

ChemX Materials Limited (ASX:CMX) (ChemX or the Company), an Australian high purity critical materials company and 100%-owner of the HiPurA® patented process to produce High Purity Alumina (HPA) in O’Connor, Western Australia is pleased to advise it has received its FY24 R&D Refund from the ATO.

ChemX Receives $661,890 R&D Refund
Radium Capital Facility Repaid

As announced to ASX on 6th September 2024, the Company obtained an advance against its expected R&D Return. The refund received extinguishes the facility taken out with Radium Capital for $442,000. After repayment of fees and charges for the facility the Company has received a surplus of $207,381. The surplus will be used towards working capital for the Company.

Click here for the full ASX Release

This article includes content from ChemX Materials, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
Warring GOP factions strike deal to raise threshold to oust a House speaker
next post
Matt Gaetz resigns from Congress over Trump nod to be attorney general, Johnson says

You may also like

JZR Gold Inc. Provides an Update Regarding the...

Ti-Tree Money Intrusion Ni-Cu-PGE Update

Brunswick Exploration Drills 37 Meters at 1.14% Extending...

Types of Iron Ore: Hematite vs. Magnetite

Top 9 Lithium-producing Countries

Westport Announces Director Retirement

Spearmint More Than Doubles the Acreage of the...

Alvopetro Announces March 2025 Sales Volumes

Sona Nanotech’s THT Cancer Therapy Preclinical Efficacy Studies...

Bold Stakes Claims Near Springpole and Grants Options

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Liverpool car ramming suspect appears in court after crash that shocked the...

    • Group Eleven Announces Appointment of Jasmine Lau as Chief Financial Officer

    • Russell Brand pleads not guilty to rape and sexual assault charges

    • Russian captain involved in US tanker crash pleads not guilty to manslaughter in UK court

    • How Rotimi and Vanessa Mdee’s chance romance became a deep dive into faith and purpose

    Categories

    • Business (477)
    • Investing (2,266)
    • Politics (3,709)
    • Uncategorized (1)
    • World (2,395)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: uniquecryptostrategies.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 uniquecryptostrategies.com | All Rights Reserved


    Back To Top